Market Cap 4.43M
Revenue (ttm) 0.00
Net Income (ttm) -21.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 11,000
Avg Vol 52,990
Day's Range N/A - N/A
Shares Out 1.32M
Stochastic %K 64%
Beta 1.32
Analysts Hold
Price Target $6.00

Company Profile

Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

Industry: Biotechnology
Sector: Healthcare
Phone: 45 70 70 52 10
Website: galecto.com
Address:
Ole Maaloes Vej 3, Copenhagen N, Copenhagen, Denmark
globaldaytraderzzzzzzz
globaldaytraderzzzzzzz Jun. 12 at 1:02 PM
$GLTO # wo to ldwide slap nowww
0 · Reply
Investor1337
Investor1337 Jun. 4 at 6:01 PM
$GLTO Hans finally removed phantom tax in Denmark. Too bad he used all his time on that project instead instead of GLTO
0 · Reply
signaljumper
signaljumper Jun. 3 at 1:13 PM
$GLTO we will see again a pushto or over 7$ like last time
0 · Reply
privatebio
privatebio May. 25 at 8:12 PM
0 · Reply
sixmilliondollarman
sixmilliondollarman May. 22 at 5:33 PM
$GLTO 👀 Peer group targeting galectin-3 consists of $GALT $BIXT & private TrueBinding. GALT market cap is 20X higher than GLTO. Drug is large molecule, IV delivered. Missed endpoints in P3. Runway is 3 months. Maybe still a path forward. BIXT is an OTCQB scam company. Chewable polysaccharide for covid -19. Last data from 2020 on just 10 pts. Been talking about P3 for THREE years. Zero cash. Market cap is 3X higher. An interesting aside is BIXT founder & CEO founded GALT 😂 Then there’s TrueBinding with IV delivered monoclonal antibody in P2 for autism spectrum disorder & Parkinson’s. Post money valuation is ~$1B, valued ~700X higher than GLTO 🤷‍♂️
1 · Reply
1ktrades
1ktrades May. 21 at 3:23 PM
$GLTO this shi ain’t accurate 75% of the time..
0 · Reply
signaljumper
signaljumper May. 19 at 7:58 PM
$GLTO looking goood
0 · Reply
Investor1337
Investor1337 May. 19 at 6:53 PM
$GLTO GB1211: Melanoma AND HNSCC = study exploring the combination of pembrolizumab (Keytruda®) and Galecto’s GB1211 "Tumor volume will be assessed by immune response RECIST criteria (iRECIST criteria 1.1). It is anticipated that early data from this trial could be available as EARLY AS 2025." 11 days more we either fly or fall
1 · Reply
canwecomeback
canwecomeback May. 19 at 11:11 AM
$GLTO i wish i never heard about this stock..
0 · Reply
ahTony
ahTony May. 19 at 7:56 AM
Premarket watchlist $HCTI $GRNQ $ASST $GLTO $ABP
0 · Reply
Latest News on GLTO
Galecto Reports Full-Year 2024 Financial Results

Mar 19, 2025, 4:45 PM EDT - 3 months ago

Galecto Reports Full-Year 2024 Financial Results


Galecto to Participate in Upcoming Investor Conferences

Feb 6, 2025, 8:00 AM EST - 4 months ago

Galecto to Participate in Upcoming Investor Conferences


Galecto Reports Third Quarter 2024 Financial Results

Nov 1, 2024, 8:30 AM EDT - 8 months ago

Galecto Reports Third Quarter 2024 Financial Results


Galecto Announces Reverse Stock Split

Aug 28, 2024, 9:00 AM EDT - 10 months ago

Galecto Announces Reverse Stock Split


Galecto Announces Plans to Explore Strategic Alternatives

Sep 26, 2023, 4:01 PM EDT - 1 year ago

Galecto Announces Plans to Explore Strategic Alternatives


Galecto to Present at Investor Conferences in September

Aug 31, 2023, 11:00 AM EDT - 1 year ago

Galecto to Present at Investor Conferences in September


Galecto to discontinue development of lung disease treatment

Aug 15, 2023, 7:55 AM EDT - 1 year ago

Galecto to discontinue development of lung disease treatment


Galecto Reports Second Quarter Operating and Financial Results

Jul 31, 2023, 4:05 PM EDT - 2 years ago

Galecto Reports Second Quarter Operating and Financial Results


Galecto Set to Join Russell Microcap® Index

Jun 20, 2023, 8:58 AM EDT - 2 years ago

Galecto Set to Join Russell Microcap® Index


Galecto Reports First Quarter Operating and Financial Results

Apr 28, 2023, 8:00 AM EDT - 2 years ago

Galecto Reports First Quarter Operating and Financial Results


Galecto: Promising Pipeline And Excellent Risk-Reward

Apr 18, 2023, 7:01 PM EDT - 2 years ago

Galecto: Promising Pipeline And Excellent Risk-Reward


Galecto to Present Two Posters at AACR Annual Meeting 2023

Apr 13, 2023, 8:30 AM EDT - 2 years ago

Galecto to Present Two Posters at AACR Annual Meeting 2023


Galecto Reports Third Quarter Operating and Financial Results

Nov 8, 2022, 9:15 AM EST - 2 years ago

Galecto Reports Third Quarter Operating and Financial Results


Galecto to Participate at Jefferies Healthcare Conference

May 31, 2022, 8:30 AM EDT - 3 years ago

Galecto to Participate at Jefferies Healthcare Conference


Galecto to Present at Upcoming Investor Conferences

Oct 26, 2021, 8:00 AM EDT - 3 years ago

Galecto to Present at Upcoming Investor Conferences


globaldaytraderzzzzzzz
globaldaytraderzzzzzzz Jun. 12 at 1:02 PM
$GLTO # wo to ldwide slap nowww
0 · Reply
Investor1337
Investor1337 Jun. 4 at 6:01 PM
$GLTO Hans finally removed phantom tax in Denmark. Too bad he used all his time on that project instead instead of GLTO
0 · Reply
signaljumper
signaljumper Jun. 3 at 1:13 PM
$GLTO we will see again a pushto or over 7$ like last time
0 · Reply
privatebio
privatebio May. 25 at 8:12 PM
0 · Reply
sixmilliondollarman
sixmilliondollarman May. 22 at 5:33 PM
$GLTO 👀 Peer group targeting galectin-3 consists of $GALT $BIXT & private TrueBinding. GALT market cap is 20X higher than GLTO. Drug is large molecule, IV delivered. Missed endpoints in P3. Runway is 3 months. Maybe still a path forward. BIXT is an OTCQB scam company. Chewable polysaccharide for covid -19. Last data from 2020 on just 10 pts. Been talking about P3 for THREE years. Zero cash. Market cap is 3X higher. An interesting aside is BIXT founder & CEO founded GALT 😂 Then there’s TrueBinding with IV delivered monoclonal antibody in P2 for autism spectrum disorder & Parkinson’s. Post money valuation is ~$1B, valued ~700X higher than GLTO 🤷‍♂️
1 · Reply
1ktrades
1ktrades May. 21 at 3:23 PM
$GLTO this shi ain’t accurate 75% of the time..
0 · Reply
signaljumper
signaljumper May. 19 at 7:58 PM
$GLTO looking goood
0 · Reply
Investor1337
Investor1337 May. 19 at 6:53 PM
$GLTO GB1211: Melanoma AND HNSCC = study exploring the combination of pembrolizumab (Keytruda®) and Galecto’s GB1211 "Tumor volume will be assessed by immune response RECIST criteria (iRECIST criteria 1.1). It is anticipated that early data from this trial could be available as EARLY AS 2025." 11 days more we either fly or fall
1 · Reply
canwecomeback
canwecomeback May. 19 at 11:11 AM
$GLTO i wish i never heard about this stock..
0 · Reply
ahTony
ahTony May. 19 at 7:56 AM
Premarket watchlist $HCTI $GRNQ $ASST $GLTO $ABP
0 · Reply
resistancebreakers
resistancebreakers May. 17 at 6:52 PM
$GLTO jumping Monday? This one was identified and suggested for monitoring in our Discord last month 🕵️‍♂️🪖
0 · Reply
NinjaRai
NinjaRai May. 17 at 9:52 AM
$GLTO last updated price: 2.85$ Support (S) S3: 2.71$ S2: 2.91 $ S3: 3 $ Resist (R) R1: 3.29$ R2: 3.49$ R3: 3.58$ What do you think ? 🚨
0 · Reply
sixmilliondollarman
sixmilliondollarman May. 16 at 8:18 PM
$GLTO YouTube vid triggered a pre market bio twitter pump to $4.20. But in just 5 minutes it was hammered down to $2.25 spooking traders. Very curious trading. Someone is holding this down. News soon
0 · Reply
GluttonBoy
GluttonBoy May. 16 at 6:50 PM
$GLTO if you actually do research and compare them to other biotechs you’ll see that this should be a $100M+ company..and is sitting at a $4M MC as we speak .
0 · Reply
sixmilliondollarman
sixmilliondollarman May. 16 at 5:54 PM
$GLTO 👀 the street hasn’t yet appreciated GB3226 but soon will. Daiichi paid $400M for an FLT3 drug in P3. There are only 3 on the market, the other two from Astellas and Novartis. The AML market is $1.5-2B. GB3226 is showing significantly superior efficacy so far in preclinical models. And just as important minus the tox of the other three which come with a box warning. IND is expected end of year or early ‘26. This is a breakthrough drug from collaborative research from Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine. Here’s the kicker. The new head of FDA has announced a new pathway for drug approvals targeting rare diseases. AML is a rare disease. This pathway allows for mechanistic approval. Along with the significant real world data from the 3 approved drugs this could reach the market much faster, possibly without an RCT 🤷‍♂️
0 · Reply
_www_larval_com_
_www_larval_com_ May. 16 at 3:17 PM
$GLTO has turned -5% lower to 1% (~952Kv) a moment ago, follow for more volatility.
0 · Reply
arribaStocktrading
arribaStocktrading May. 16 at 2:17 PM
$GLTO Strong volume today. Good to see!
0 · Reply
frankyboyz
frankyboyz May. 16 at 2:01 PM
$GLTO 3.30 $GLTO off 2.40 dips given Almos 40% so far, u r welcome
0 · Reply
PennyStocksMom
PennyStocksMom May. 16 at 12:50 PM
🌅🌅 watchlist ✅️ $TGL low 2.20 support, if above 2.65, have potential to 2.80/90, small float, up over 73% from swing alert posted below 2, CONGRATS if you got in below 2 during swing accumulation phase ✅️ $CAPS low 3 support, if above 3.50, have potential to 4 ✅️ $AMST low 4 support, if above 4.40, have potential to 4.70/80, ✅️ $CABA low 2 support, if above 2.55, have potential to 2.75/.80, ✅️ $GLTO mid 2.50 support, if above 3.0, have potential to 3.5/4, ✅️ ZENA low 2.20 support, if above 2.60, have potential to 2.80/3, , up on earnings ✅️ SPCE mid 3.50 support, if above 4, have potential to 4.50 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if below current support 🚫🚫 Avoid chasing long into strength near resistance. 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
1 · Reply
StockfatherOG
StockfatherOG May. 16 at 12:50 PM
$GLTO great swing setup here. Dips will definitely pay off.
0 · Reply
delvanbeyond
delvanbeyond May. 16 at 12:38 PM
$GLTO heading past the moon. 🌒
0 · Reply
frankyboyz
frankyboyz May. 16 at 12:17 PM
$GLTO 2.40 dips paying, about to break 3? $GLTO i knew that dip was exagerated
0 · Reply